Prokidney (PROK) Consolidated Net Income (2021 - 2026)

Prokidney's (PROK) quarterly Consolidated Net Income came in at -$42.6 million in Q1 2026, down 12.3% year-on-year from -$48.6 million in Q1 2025, and down 390.69% on a QoQ basis from -$8.7 million in Q4 2025.

Prokidney (PROK) Consolidated Net Income (2021 - 2026) Analysis & Trends

Prokidney (PROK) has 6 years of Consolidated Net Income data on file, last reported at -$42.6 million in Q1 2026.

  • On a quarterly basis, Consolidated Net Income fell 12.3% year-over-year to -$42.6 million in Q1 2026; TTM through Mar 2026 was -$124.1 million, a 25.21% increase from a year earlier, with the FY2025 full-year figure at -$119.4 million, up 26.87% from the prior year.
  • Consolidated Net Income for Q1 2026 stood at -$42.6 million, down from -$8.7 million in the prior quarter.
  • Over the last five years, Consolidated Net Income for PROK reached as high as -$8.7 million in Q4 2025 and fell as low as -$67.5 million in Q1 2022.
  • Historically, Consolidated Net Income has averaged -$35.8 million across 5 years, with a median of -$36.9 million in 2023.
  • Across the five-year window, Consolidated Net Income tumbled 415505.63% in 2022 and soared 82.08% in 2025, its largest moves.
  • Year by year, Consolidated Net Income stood at -$24.6 million in 2022, then grew by 11.59% to -$21.7 million in 2023, then slumped by 123.18% to -$48.5 million in 2024, then surged by 82.08% to -$8.7 million in 2025, then slumped by 390.69% to -$42.6 million in 2026.
  • Per Business Quant data, the three most recent Consolidated Net Income figures were -$42.6 million in Q1 2026, -$8.7 million in Q4 2025, and -$35.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Oculis Holding AG 65,839.48 Bn 65,839.20 Bn - -37.09 Mn
2 Nanobiotix 1,933.82 Bn 1,933.76 Bn - -
3 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - -14.46 Mn
4 BeOne Medicines 472.40 Bn 467.61 Bn 1.35 Bn 227.36 Mn
5 Vertex Pharmaceuticals 122.23 Bn 114.98 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 70.05 Bn 61.29 Bn 3.31 Bn 727.20 Mn
7 Belite Bio 62.46 Bn 62.46 Bn - -26.94 Mn
8 Argenx Se 55.94 Bn 50.76 Bn 1.41 Bn 362.00 Mn
9 Alnylam Pharmaceuticals 37.52 Bn 34.51 Bn 959.66 Mn 205.99 Mn
10 Prokidney 95.39 Mn 95.39 Mn - -42.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -42.62 Mn
Dec 31, 2025 -8.69 Mn
Sep 30, 2025 -35.84 Mn
Jun 30, 2025 -36.97 Mn
Mar 31, 2025 -37.95 Mn
Dec 31, 2024 -48.48 Mn
Sep 30, 2024 -41.05 Mn
Jun 30, 2024 -38.47 Mn
Mar 31, 2024 -35.33 Mn
Dec 31, 2023 -21.72 Mn
Sep 30, 2023 -41.99 Mn
Jun 30, 2023 -34.82 Mn
Mar 31, 2023 -36.91 Mn
Dec 31, 2022 -24.57 Mn
Sep 30, 2022 -33.95 Mn
Jun 30, 2022 -22.13 Mn
Mar 31, 2022 -67.49 Mn
Dec 31, 2021 -13.82 Mn
Sep 30, 2021 -17.02 Mn
Jun 30, 2021 -5,325.00